DRI vs PPCB · P/E 22, rev $12.08B vs P/E 0.0, $3.9M cap
Darden Restaurants Inc (DRI) versus Propanc Biopharma, Inc. Common Stock (PPCB) — a side-by-side from cached financials, not a winner call.
Darden Restaurants Inc (DRI) is a restaurants company listed on NYSE.
Propanc Biopharma, Inc. Common Stock (PPCB) is a biotechnology company listed on NASDAQ.
Latest reported DRI revenue for 2025-05-25 was $12.08B. Net income was $1.05B. Revenue was up 6.0% from 2024-05-26 to 2025-05-25. DRI currently screens at market cap $24.20B and trailing P/E 22.3.
PPCB does not have a complete income-statement cache yet.
DRI currently screens at market cap $24.20B and trailing P/E 22.3. PPCB currently screens at market cap $3.9M and trailing P/E 0.0.
Not investment advice. Open the DRI and PPCB stock pages for the full models.
Not investment advice.